Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers

摘要

Outcomes of patients with early-stage multiple primary lung cancers (MPLC) were reviewed from a prospective database at a high-volume institution. Compared to patients receiving a single course of stereotactic body radiotherapy (SBRT), MPLC patients receiving multiple courses of SBRT or receiving surgery followed by SBRT had no significant detriment in survival, freedom from disease progression, or toxicity.